Glycans in Diseases and Therapeutics

Glycomedicine functions as essential role in cell-cell adhesion i.e. a device used by cells of the immune system through sugar-binding proteins called lectins, which classify precise carbohydrate portions. Glycans (carbohydrate oligomers) are the so-called “building blocks” of carbohydrates, nucleic acids, proteins and lipids play leading roles in various biological phenomena as well as in numerous pathophysiological procedures. Several scientists have now understood that glycosylation, i.e. the count of glycans to a protein backbone, is the most plentiful post translational alteration responses and is a major field of research and sometimes they require a glycobiology method to be exploited

    Related Conference of Glycans in Diseases and Therapeutics

    November 27-28, 2024

    14th World Congress on Analytical & Bioanalytical Techniques

    Amsterdam, Netherlands
    November 28-29, 2024

    20th European Organic Chemistry Congress

    Paris, France
    December 12-13, 2024

    23rd World Congress on Nutrition and Food Chemistry

    Rome, Italy
    December 18-19, 2024

    4th International Conference on Petrochemistry and Natural Gas

    Amsterdam, Netherlands
    January 27-28, 2025

    25th World Congress on Medicinal Chemistry and Drug Design

    Bangkok, Thailand
    March 13-14, 2025

    2nd International Conference on Drug Discovery and Development

    Prague, Czech Republic
    April 07-08, 2025

    15th World Congress on Chemistry

    Vancouver, Canada
    May 14-15, 2025

    17th International Conference on Clinical Chemistry

    Toronto, Canada
    June 26-27, 2025

    14th World Congress on Chromatography

    Paris, France

    Glycans in Diseases and Therapeutics Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in